Latest Antipsychotic Stories
Results served as basis for regulatory filing with U.S.
Citizens Commission on Human Rights (CCHR), a leading mental health watchdog, announces its support for newly introduced legislation in the state of California with its latest press release, applauding
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
- Treatment for Major Depressive Disorder (MDD) in Adults- DUBLIN, March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the U.S.
- First atypical antipsychotic to be approved for pediatric patients with bipolar I disorder in the last five years - DUBLIN, March 13, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced
The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with
The Firm is currently representing numerous Risperdal lawsuit plaintiffs who raise similar questions regarding the tactics used to drive sales of the atypical antipsychotic medication.
Pharmaceutical manufacturer, Johnson & Johnson, loses $2.5 million verdict for marketing of Risperdal, a potent antipsychotic that caused female breast growth in a young boy the case revealed.
The Risperdal trial currently underway in the Pennsylvania mass tort, where Bernstein Liebhard LLP is actively filing claims, is the first to involve gynecomastia, and could provide insight into
The Firm is representing numerous plaintiffs who have also filed Risperdal lawsuits alleging the atypical antipsychotic medication caused male breast growth. New
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.